— Know what they know.
Not Investment Advice
Also trades as: IBO.V (TSXV) · $vol 0M

IBOGF OTC

Universal Ibogaine Inc.
1W: -99.0% 1M: -99.5% 3M: -99.6% YTD: -98.0% 1Y: -98.8% 3Y: -99.1%
$0.00
-0.00 (-50.00%)
 
Weekly Expected Move ±623575.0%
$-1 $-1 $0 $1 $1
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $31286 mcap · 303M float · 0.094% daily turnover · Short 81% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M -33.3% ▼
Capital Expenditures
$96K +0.0% ▲
Free Cash Flow
-$4M -36.3% ▼
Dividends Paid
$0 +100.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
$584K +551.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$408K-$98K-$118K-$4M-$10M
Depreciation & Amort.$0$0$255$70K$266K
Stock-Based Comp.$94K$0$0$0$904K
Change in Working Capital-$6K$26K-$4K-$282K-$508K
Other Non-Cash Items$0$0$0$830K$3M
Operating Cash Flow-$320K-$72K-$122K-$3M-$4M
— Investing Activities —
Capital Expenditures$0$0-$2K$0-$96K
Acquisitions (Net)$0$0$0$0-$2M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$225K$225K-$25K-$43K$55K
Investing Cash Flow-$225K$225K-$27K-$43K-$2M
— Financing Activities —
Net Debt Issuance—————
Stock Repurchased$0$0$0-$46K$0
Dividends Paid$0$0$0-$410K$0
Other Financing$0$0$0$620K$1M
Financing Cash Flow$210K$0$16K$3M$7M
Net Change in Cash-$336K$153K-$132K$90K$584K
Cash End of Period$52K$205K$72K$142K$726K
Free Cash Flow-$320K-$72K-$124K-$3M-$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms